11![Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:](https://www.pdfsearch.io/img/0378515d0df0f3c8e9b7d3f7b8ebc821.jpg) | Add to Reading ListSource URL: www.fdhc.state.fl.usLanguage: English - Date: 2012-09-25 12:12:06
|
---|
12![PHARMACIST Give to Patient Patient Instructions for Use Nasal Spray (olopatadine hydrochloride) PHARMACIST Give to Patient Patient Instructions for Use Nasal Spray (olopatadine hydrochloride)](https://www.pdfsearch.io/img/2e011ade960875cb9f075a7bcb19bc19.jpg) | Add to Reading ListSource URL: ecatalog.alcon.comLanguage: English - Date: 2014-08-21 13:04:53
|
---|
13![These highlights do not include all the information needed to use PATANASE® Nasal Spray safely and effectively. See full prescribing information for PATANASE Nasal Spray. PATANASE (olopatadine hydrochloride) Nasal Spray These highlights do not include all the information needed to use PATANASE® Nasal Spray safely and effectively. See full prescribing information for PATANASE Nasal Spray. PATANASE (olopatadine hydrochloride) Nasal Spray](https://www.pdfsearch.io/img/0438905d7a5e039f3073d290c0848917.jpg) | Add to Reading ListSource URL: ecatalog.alcon.comLanguage: English - Date: 2014-08-21 13:04:53
|
---|
14![HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS](https://www.pdfsearch.io/img/61b4249704dcec9b3839ac8416f1f5e8.jpg) | Add to Reading ListSource URL: ecatalog.alcon.comLanguage: English - Date: 2014-08-21 13:04:53
|
---|
15![Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet * Patanase Spray (olopatadine HCl) * Astepro Spray (azelastine HCl) * Bepreve (bepotastine besilate ophthalmic solution) 1.5% * Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet * Patanase Spray (olopatadine HCl) * Astepro Spray (azelastine HCl) * Bepreve (bepotastine besilate ophthalmic solution) 1.5% *](https://www.pdfsearch.io/img/80906afff56f8536cc6d28850e438e3b.jpg) | Add to Reading ListSource URL: www.fda.gov |
---|
16![CLINICAL REVIEW Application Type Submission Number Submission Code CLINICAL REVIEW Application Type Submission Number Submission Code](https://www.pdfsearch.io/img/311ede52e4205c36a83acaa0bdfc71f6.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
17![022288_Bepotastine_Clinical_PREA 022288_Bepotastine_Clinical_PREA](https://www.pdfsearch.io/img/13f1f2290f06fe88a6ad00e8f53aa43d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
18![Statistical Review and Evaluation Clinical Studies Statistical Review and Evaluation Clinical Studies](https://www.pdfsearch.io/img/06bc2ec882987fa19b53264a6abb179a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
19![Clinical Pharmacology Review Clinical Pharmacology Review](https://www.pdfsearch.io/img/59571e097db16f820004b2edf97309f5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
20![Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology](https://www.pdfsearch.io/img/65fe53e39218f8d8aa1997454603b28f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|